David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Nice
NICE
$5.92B
| $3.29M | ﹤0.01% |
26,890
+5,772
| +27% | +$650K |
|
1777
CRA International
CRAI
$1.07B
| $3.29M | ﹤0.01% |
65,143
-157
| -0.2% | -$7.09K |
|
1778
CALL
Nexstar Media Group
NXST
$5.72B
| $3.28M | ﹤0.01% |
30,300
+15,000
| +98% | +$1.38M |
|
1779
CALL
Las Vegas Sands
LVS
$29.9B
| $3.28M | ﹤0.01% |
+53,800
| New | +$3.17M |
|
1780
CALL
Children's Place
PLCE
$59.4M
| $3.28M | ﹤0.01% |
+33,700
| New | +$3.07M |
|
1781
PUT
PNC Financial Services
PNC
$97.6B
| $3.27M | ﹤0.01% |
26,700
+8,200
| +44% | +$1.02M |
|
|
DCH
1782
Dauch Corp
DCH
$1.52B
| $3.27M | ﹤0.01% |
+228,786
| New | +$3.31M |
|
1783
Globant
GLOB
$1.67B
| $3.27M | ﹤0.01% |
45,837
+27,204
| +146% | +$1.83M |
|
1784
Turkcell
TKC
$4.72B
| $3.27M | ﹤0.01% |
610,012
-474,174
| -44% | -$3.02M |
|
|
CKH
1785
DELISTED
Seacor Holdings Inc.
CKH
| $3.26M | ﹤0.01% |
77,056
-33,806
| -30% | -$1.44M |
|
|
BROG
1786
DELISTED
Brooge Energy
BROG
| $3.26M | ﹤0.01% |
325,000
| – | – |
|
1787
Protagonist Therapeutics
PTGX
$9.8B
| $3.24M | ﹤0.01% |
257,728
+238,083
| +1,212% | +$2.1M |
|
1788
Equifax
EFX
$22.4B
| $3.23M | ﹤0.01% |
27,303
-103,736
| -79% | -$11.1M |
|
1789
Booz Allen Hamilton
BAH
$8.93B
| $3.23M | ﹤0.01% |
55,582
-20,930
| -27% | -$1.09M |
|
1790
PUT
Cracker Barrel
CBRL
$1.31B
| $3.23M | ﹤0.01% |
20,000
+5,000
| +33% | +$822K |
|
|
MINI
1791
DELISTED
Mobile Mini Inc
MINI
| $3.23M | ﹤0.01% |
95,000
-17,461
| -16% | -$620K |
|
1792
Teva Pharmaceuticals
TEVA
$44.2B
| $3.22M | ﹤0.01% |
205,577
-440,775
| -68% | -$7.77M |
|
|
DLPH
1793
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $3.21M | ﹤0.01% |
166,400
+13,600
| +9% | +$252K |
|
1794
CALL
Crown Castle
CCI
$32.1B
| $3.2M | ﹤0.01% |
25,000
-121,500
| -83% | -$14.3M |
|
1795
PUT
Core Laboratories
CLB
$550M
| $3.2M | ﹤0.01% |
46,400
+26,800
| +137% | +$1.8M |
|
1796
Energizer
ENR
$1.5B
| $3.19M | ﹤0.01% |
71,056
+12,403
| +21% | +$572K |
|
1797
Kearny Financial
KRNY
$639M
| $3.19M | ﹤0.01% |
247,948
+66,643
| +37% | +$875K |
|
1798
CALL
NetEase
NTES
$79B
| $3.19M | ﹤0.01% |
66,000
-1,500
| -2% | -$71.3K |
|
1799
Invesco
IVZ
$14.6B
| $3.19M | ﹤0.01% |
164,953
+53,161
| +48% | +$994K |
|
1800
WillScot Mobile Mini Holdings
WSC
$3.87B
| $3.18M | ﹤0.01% |
+287,098
| New | +$2.98M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.